I

n a high-stakes battle between drug makers and insurers, last week it was the drug makers who got a lift, on a little-noticed issue and in an unusual place: Arkansas.

The governor there signed legislation to make Arkansas the 43rd state since 2008 to enact so-called oral parity laws, which prohibit certain private insurers from charging cancer patients more in copays if they take chemo in pill form instead of getting it infused into their veins. Patient groups are pushing similar legislative campaigns in North Carolina, Tennessee, Michigan, and at the federal level.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Biotech newsletter — The Readout

Your daily guide to what’s new in biotech.